Grant Number:	5R01CA251555-04 Interpret this number
Primary Investigator:	Freedman, Matthew
Organization:	Dana-Farber Cancer Inst
Project Title:	Elucidation of the Genetic Mechanisms Driving Prostate Tumorigenesis Through Integrative Computational and Functional Approaches
Fiscal Year:	2024

PROJECT SUMMARY/ABSTRACT Although genome-wide association studies (GWAS) have been extremely successful in identifying numerous germline variants associated to risk for prostate cancer, the causal mechanism between genetic variation and disease risk remains largely unknown at the vast majority of these loci. This prohibits the full realization of novel drug targets and/or personalized treatments. In the quest to address this gap, post-GWAS studies are experiencing a “big data” revolution driven by the exponentially decreasing costs of high-throughput genomic assays. Multiple layers of data (genetic variation, transcriptome levels, epigenetic modifications, localization of tissue-specific regulatory sites, 3D interactions, etc.) are routinely collected in increasingly large cohorts of individuals. This raises the need for rigorous computational and experimental frameworks that integrate various types of data to identify and validate causal genes and variants in prostate cancer. Here we propose a rigorous framework aimed at loci where risk is mediated through alteration in gene expression levels. We deliberately and exhaustively propose to examine all risk loci for prostate cancer to prioritize causal variants and genes and to functionally validate them in prostate cancer tissue and cell lines.




Detecting Small Cell Transformation in Patients with Advanced EGFR Mutant Lung Adenocarcinoma through Epigenomic cfDNA Profiling.
Authors: El Zarif T. , Meador C.B. , Qiu X. , Seo J.H. , Davidsohn M.P. , Savignano H. , Lakshminarayanan G. , McClure H.M. , Canniff J. , Fortunato B. , et al. .
Source: Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research, 2024-09-03 00:00:00.0; 30(17), p. 3798-3811.
PMID: 38912901
Related Citations

The PENGUIN approach to reconstruct protein interactions at enhancer-promoter regions and its application to prostate cancer.
Authors: Armaos A. , Serra F. , Núñez-Carpintero I. , Seo J.H. , Baca S.C. , Gustincich S. , Valencia A. , Freedman M.L. , Cirillo D. , Giambartolomei C. , et al. .
Source: Nature Communications, 2023-12-06 00:00:00.0; 14(1), p. 8084.
EPub date: 2023-12-06 00:00:00.0.
PMID: 38057321
Related Citations

Isoform-level transcriptome-wide association uncovers genetic risk mechanisms for neuropsychiatric disorders in the human brain.
Authors: Bhattacharya A. , Vo D.D. , Jops C. , Kim M. , Wen C. , Hervoso J.L. , Pasaniuc B. , Gandal M.J. .
Source: Nature Genetics, 2023-11-30 00:00:00.0; , .
EPub date: 2023-11-30 00:00:00.0.
PMID: 38036788
Related Citations

Interplay Of Serum Bilirubin and Tobacco Smoking with Lung and Head and Neck Cancers in a Diverse, EHR-linked Los Angeles Biobank.
Authors: Venkateswaran V. , Petter E. , Boulier K. , Ding Y. , Bhattacharya A. , Pasaniuc B. .
Source: Research Square, 2023-10-24 00:00:00.0; , .
EPub date: 2023-10-24 00:00:00.0.
PMID: 37961486
Related Citations

Interplay Of Serum Bilirubin and Tobacco Smoking with Lung and Head and Neck Cancers in a Diverse, EHR-linked Los Angeles Biobank.
Authors: Venkateswaran V. , Petter E. , Boulier K. , Ding Y. , Bhattacharya A. , Pasaniuc B. .
Source: Medrxiv : The Preprint Server For Health Sciences, 2023-10-03 00:00:00.0; , .
EPub date: 2023-10-03 00:00:00.0.
PMID: 37873378
Related Citations

A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus.
Authors: Spisak S. , Tisza V. , Nuzzo P.V. , Seo J.H. , Pataki B. , Ribli D. , Sztupinszki Z. , Bell C. , Rohanizadegan M. , Stillman D.R. , et al. .
Source: Nature Communications, 2023-08-23 00:00:00.0; 14(1), p. 5118.
EPub date: 2023-08-23 00:00:00.0.
PMID: 37612286
Related Citations

Genotype error due to low-coverage sequencing induces uncertainty in polygenic scoring.
Authors: Petter E. , Ding Y. , Hou K. , Bhattacharya A. , Gusev A. , Zaitlen N. , Pasaniuc B. .
Source: American Journal Of Human Genetics, 2023-08-03 00:00:00.0; 110(8), p. 1319-1329.
EPub date: 2023-07-24 00:00:00.0.
PMID: 37490908
Related Citations

Epigenomic charting and functional annotation of risk loci in renal cell carcinoma.
Authors: Nassar A.H. , Abou Alaiwi S. , Baca S.C. , Adib E. , Corona R.I. , Seo J.H. , Fonseca M.A.S. , Spisak S. , El Zarif T. , Tisza V. , et al. .
Source: Nature Communications, 2023-01-21 00:00:00.0; 14(1), p. 346.
EPub date: 2023-01-21 00:00:00.0.
PMID: 36681680
Related Citations

Nucleosome patterns in circulating tumor DNA reveal transcriptional regulation of advanced prostate cancer phenotypes.
Authors: De Sarkar N. , Patton R.D. , Doebley A.L. , Hanratty B. , Adil M. , Kreitzman A.J. , Sarthy J.F. , Ko M. , Brahma S. , Meers M.P. , et al. .
Source: Cancer Discovery, 2022-11-18 00:00:00.0; , .
EPub date: 2022-11-18 00:00:00.0.
PMID: 36399432
Related Citations

Best practices for multi-ancestry, meta-analytic transcriptome-wide association studies: Lessons from the Global Biobank Meta-analysis Initiative.
Authors: Bhattacharya A. , Hirbo J.B. , Zhou D. , Zhou W. , Zheng J. , Kanai M. , Global Biobank Meta-analysis Initiative , Pasaniuc B. , Gamazon E.R. , Cox N.J. .
Source: Cell Genomics, 2022-10-12 00:00:00.0; 2(10), .
PMID: 36341024
Related Citations

Leveraging genomic diversity for discovery in an electronic health record linked biobank: the UCLA ATLAS Community Health Initiative.
Authors: Johnson R. , Ding Y. , Venkateswaran V. , Bhattacharya A. , Boulier K. , Chiu A. , Knyazev S. , Schwarz T. , Freund M. , Zhan L. , et al. .
Source: Genome Medicine, 2022-09-09 00:00:00.0; 14(1), p. 104.
EPub date: 2022-09-09 00:00:00.0.
PMID: 36085083
Related Citations

Patterns of structural variation define prostate cancer across disease states.
Authors: Zhou M. , Ko M. , Hoge A.C. , Luu K. , Liu Y. , Russell M.L. , Hannon W.W. , Zhang Z. , Carrot-Zhang J. , Beroukhim R. , et al. .
Source: Jci Insight, 2022-09-08 00:00:00.0; 7(17), .
EPub date: 2022-09-08 00:00:00.0.
PMID: 35943799
Related Citations

Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate Cancer.
Authors: Berchuck J.E. , Boiarsky D. , Silver R. , Sunkara R. , McClure H.M. , Tsai H.K. , Siegmund S. , Tewari A.K. , Nowak J.A. , Lindeman N.I. , et al. .
Source: Jco Precision Oncology, 2022 Aug; 6, p. e2200329.
PMID: 36103646
Related Citations

Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistrome.
Authors: Qiu X. , Brown L.G. , Conner J.L. , Nguyen H.M. , Boufaied N. , Abou Alaiwi S. , Seo J.H. , El Zarif T. , Bell C. , O'Connor E. , et al. .
Source: Jci Insight, 2022-05-23 00:00:00.0; 7(10), .
EPub date: 2022-05-23 00:00:00.0.
PMID: 35603787
Related Citations

MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets.
Authors: Qiu X. , Boufaied N. , Hallal T. , Feit A. , de Polo A. , Luoma A.M. , Alahmadi W. , Larocque J. , Zadra G. , Xie Y. , et al. .
Source: Nature Communications, 2022-05-13 00:00:00.0; 13(1), p. 2559.
EPub date: 2022-05-13 00:00:00.0.
PMID: 35562350
Related Citations

HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer.
Authors: Lu X. , Fong K.W. , Gritsina G. , Wang F. , Baca S.C. , Brea L.T. , Berchuck J.E. , Spisak S. , Ross J. , Morrissey C. , et al. .
Source: Nature Genetics, 2022 May; 54(5), p. 670-683.
EPub date: 2022-04-25 00:00:00.0.
PMID: 35468964
Related Citations

A multi-level investigation of the genetic relationship between endometriosis and ovarian cancer histotypes.
Authors: Mortlock S. , Corona R.I. , Kho P.F. , Pharoah P. , Seo J.H. , Freedman M.L. , Gayther S.A. , Siedhoff M.T. , Rogers P.A.W. , Leuchter R. , et al. .
Source: Cell Reports. Medicine, 2022-03-15 00:00:00.0; 3(3), p. 100542.
EPub date: 2022-03-15 00:00:00.0.
PMID: 35492879
Related Citations

Fast estimation of genetic correlation for biobank-scale data.
Authors: Wu Y. , Burch K.S. , Ganna A. , Pajukanta P. , Pasaniuc B. , Sankararaman S. .
Source: American Journal Of Human Genetics, 2022-01-06 00:00:00.0; 109(1), p. 24-32.
EPub date: 2021-12-02 00:00:00.0.
PMID: 34861179
Related Citations

Androgen receptor and MYC equilibration centralizes on developmental super-enhancer.
Authors: Guo H. , Wu Y. , Nouri M. , Spisak S. , Russo J.W. , Sowalsky A.G. , Pomerantz M.M. , Wei Z. , Korthauer K. , Seo J.H. , et al. .
Source: Nature Communications, 2021-12-15 00:00:00.0; 12(1), p. 7308.
EPub date: 2021-12-15 00:00:00.0.
PMID: 34911936
Related Citations

H3K27ac HiChIP in prostate cell lines identifies risk genes for prostate cancer susceptibility.
Authors: Giambartolomei C. , Seo J.H. , Schwarz T. , Freund M.K. , Johnson R.D. , Spisak S. , Baca S.C. , Gusev A. , Mancuso N. , Pasaniuc B. , et al. .
Source: American Journal Of Human Genetics, 2021-12-02 00:00:00.0; 108(12), p. 2284-2300.
EPub date: 2021-11-24 00:00:00.0.
PMID: 34822763
Related Citations

Prostate cancer reactivates developmental epigenomic programs during metastatic progression.
Authors: Pomerantz M.M. , Qiu X. , Zhu Y. , Takeda D.Y. , Pan W. , Baca S.C. , Gusev A. , Korthauer K.D. , Severson T.M. , Ha G. , et al. .
Source: Nature Genetics, 2020 Aug; 52(8), p. 790-799.
EPub date: 2020-07-20 00:00:00.0.
PMID: 32690948
Related Citations

A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding.
Authors: Huang Q. , Whitington T. , Gao P. , Lindberg J.F. , Yang Y. , Sun J. , Väisänen M.R. , Szulkin R. , Annala M. , Yan J. , et al. .
Source: Nature Genetics, 2014 Feb; 46(2), p. 126-35.
EPub date: 2014-01-05 00:00:00.0.
PMID: 24390282
Related Citations